ALK and lung cancer: Overexpression of miR-1343-3p and reduced expression of miR-671-3p, miR-103a-3p, let-7e, and miR-342-3p were especially distinctive in the ALK-rearranged lung cancer compared with EGFR-mutated and KRAS-mutated lung cancer [17].